The broad offering at Mannheimer Swartling is well equipped to assist with reimbursement applications, joint development projects, and matters concerning off-label use. ‘Outstanding’ practice lead Camilla Appelgren is a regulatory expert with vast experience spanning the full spectrum of R&D, market access, and licensing mandates. Peter Nilsson Torres is particularly adept at handling cases concerning trial subject and patient data. While work involving personal data processing forms a large part of Emmie Montgomery’s practice, she is also a key name for advertising and M&A mandates.
Testimonials
Collated independently by Legal 500 research team.
‘Excellent team on all levels, from partner to junior associate.’
‘Camilla Appelgren is outstanding. So are Emmie Montgomery and Peter Nilsson Torres, senior associates.’
‘Great teamwork! Professional, competent - brings clarity to complex matters.’
‘Team has extreme knowledge of the industry, massive previous experience, high competence, humbleness and hard working.’
‘Peter Nilsson Torres and Camilla Appelgren are two highly professional representatives for Mannheimer Swartling: always on time, always with the highest quality, highly competent and with a personal touch.’
‘The personal touch and very kind approach. Always easy to interact with. Nothing is impossible and a can-do attitude results in a very appreciated outcome.’
‘A practice worthy of Sweden's most highly regarded law firm. Has successfully transitioned to its new iteration under the leadership of Camilla Appelgren.’
‘Camilla Appelgren - Energetic, positive, and hardworking- a great (and rare) combination for a lawyer. Camilla is surrounded by really smart, hardworking and friendly associates - Peter Nilsson Torres and Emmie Montgomery are standouts but the whole team engenders trust.’
Key clients
- Bristol-Myers Squibb
- Celgene
- Swedish Orphan Biovitrum AB
- AbbVie AB
- Inceptua S.A.
- Lipum AB
- Capio AB
- Capio S:t Görans Sjukhus AB
- Camurus AB
- Janssen-Cilag
- Amgen
- Humana AB
- Impilo
Work highlights
- Assisted Lipum with carrying out a rights issue and entering into a strategic framework agreement regarding biological pharmaceutical manufacturing.
- Advised Impilo when entering into an agreement to divest, alongside the minority shareholders, its majority stake in Immedica Pharma as well as to reinvest to become an equal owner alongside KKR.
Lawyers
Practice head
The lawyer(s) leading their teams.
Camilla Appelgren